Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: '17 aag hydrochloride'

Search results for: '17 aag hydrochloride'

Items 31-40 of 58

Page
per page
  1. SRT1720 HCl
    A4180 SRT1720 HCl
     3 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 activator
      ≥25.3 mg/mL
  2. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  3. Lamivudine
    A8458 Lamivudine
    Target: HBV Proteases
    Summary: Nucleoside analog reverse transcriptase inhibitor
      ≥10.5 mg/mL
  4. SC-514
    B1585 SC-514
    Summary: ATP-competitive IKK-2 inhibitor, orally active
      insoluble in EtOH; insoluble in H2O; ≥50.4 mg/mL
  5. I-BET-762
    B1498 I-BET-762
     4 Citation
    Target: Bromodomains
    Summary: BET inhibitor,highly potent
      ≥21.19 mg/mL
  6. LGX818
    B1174 LGX818
    Target: Raf
    Summary: RAF inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥13.38 mg/mL
  7. Caspofungin Acetate
    B2083 Caspofungin Acetate
     1 Citation
    Summary: lipopeptide antifungal drug
      ≥60.67 mg/mL
  8. Flumethasone
    B1761 Flumethasone
    Target: Glucocorticoid Receptors
    Summary: Glucocorticoid receptor agonist
      insoluble in H2O; ≥14.3 mg/mL
  9. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  10. Lopinavir
    A8204 Lopinavir
    Summary: HIV protease inhibitor,highly potent
      ≥31.45 mg/mL

Items 31-40 of 58

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 55item
  2. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Proteasome 1 item
  3. Histone Deacetylases (HDACs) 1 item
  4. Inhibitor of apoptosis proteins (IAP) 1 item
  5. Raf 1 item
  6. Aurora Kinases 1 item
  7. EZH2 1 item
  8. Bromodomains 1 item
  9. Thymidine Phosphorylases 1 item
  10. GSK-3 1 item
  11. LPA Receptors 1 item
  12. VEGFR 1 item
  13. PDGFR 1 item
  14. Phosphodiesterases (PDEs) 2item
  15. p38 1 item
  16. MEK 2item
  17. FGFR 1 item
  18. Pim 1 item
  19. GABAB Receptors 1 item
  20. Sir2-like Family Deacetylases (Sirtuins) 1 item
  21. Deubiquitinating enzymes (DUBs) 1 item
  22. EGFR 2item
  23. FAK 1 item
  24. Syk 1 item
  25. HSP90 2item
  26. AMPK 1 item
  27. PKC 2item
  28. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  29. HER2 1 item
  30. Pyk2 1 item
  31. 5-HT2 Receptors 2item
  32. S1P receptors 1 item
  33. PKG 1 item
  34. PKA 1 item
  35. Myosin light chain kinases (MLCKs) 2item
  36. 5-HT3 Receptors 1 item
  37. Angiotensin-Converting Enzymes (ACEs) 1 item
  38. Squalene epoxidases 2item
  39. Nampt 1 item
  40. Glutamate (Metabotropic) Group I Receptors 1 item
  41. DYRK 1 item
  42. Apoptosis Inducers 1 item
  43. Glucocorticoid Receptors 1 item
  44. AChE 1 item
  45. HBV Proteases 1 item
  46. IKK 1 item
  47. Calcium-Sensing Receptors (CaSRs) 1 item
  48. CRF1 Receptors 1 item
Reported Experiments
  1. Animal Experiments 52item
  2. Cell Experiments 42item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Bacterial Infectios 1 item
  3. Bladder Cancer 2item
  4. Breast Cancer 7item
  5. Cancer 24item
  6. Cervical Cancer 1 item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 3item
  9. Colorectal Cancer 4item
  10. Erectile Dysfunction 1 item
  11. Glioblastoma 3item
  12. Glioma 2item
  13. Hepatocellular Carcinoma 1 item
  14. HIV Infections 2item
  15. Inflammatory Diseases 2item
  16. Leukemia 1 item
  17. Lung Cancer 4item
  18. Lymphoma 1 item
  19. Melanoma 5item
  20. Multidrug Resistance Studies 1 item
  21. Multiple Myeloma 4item
  22. Narcolepsy 1 item
  23. Non-small Cell Lung Cancer 2item
  24. Ovarian Cancer 1 item
  25. Pancreatic Cancer 4item
  26. Prostate Cancer 4item
  27. Schizophrenia 1 item
  28. Type 2 Diabetes 1 item